Have You Met MetS? Clinical Approach to Metabolic Syndrome

Have You Met MetS? Clinical Approach to Metabolic Syndrome

EndocrinologyFamily MedicineGeneral PracticeInternal MedicineOthers
A badge with ribbon in color black No CME/CPD credits | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 09 Jul 2027 

Overview

About

Metabolic syndrome (MetS) is a growing public health concern in Thailand, characterized by a cluster of interconnected cardiometabolic risk factors. It is a major driver of non-communicable diseases (NCDs) such as cardiovascular disease, stroke, and type 2 diabetes mellitus, which are leading causes of mortality worldwide. Given its rising prevalence and long-term clinical impact, primary care physicians play a crucial role in the early recognition and effective management of MetS.

Metabolic syndrome is diagnosed based on established clinical criteria that assess key cardiometabolic risk factors. According to the harmonized definition, MetS is present when any three of five risk factors are identified: elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein (HDL) cholesterol, elevated blood pressure, and elevated fasting glucose. In clinical practice, waist circumference is a practical marker of abdominal obesity with ethnicity-specific cut-offs being particularly important in Asian populations, including Thailand.

Metabolic syndrome management focuses on a comprehensive, patient-centered approach aimed at reducing overall cardiometabolic risk and preventing adverse health outcomes. Lifestyle modification remains the cornerstone of treatment and includes sustained weight reduction, regular physical activity, and adoption of healthy dietary patterns. Evidence-based dietary approaches such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet have been shown to improve cardiometabolic risk factors. In addition to lifestyle interventions, targeted pharmacologic therapy may be required to address individual components of metabolic syndrome, including glucose-lowering agents for impaired glycemic control, lipid-lowering therapy for dyslipidemia, and antihypertensives for elevated blood pressure.

This e-learning module provides an overview of metabolic syndrome, its diagnostic criteria, underlying pathophysiology, clinical implications, and management in primary care. It emphasizes the importance of timely identification and risk reduction to prevent long-term complications. Equipped with these insights, primary care physicians are better positioned to integrate guideline-based strategies into routine practice and improve patient outcomes.

Learning outcomes

Upon completion of this module, learners should be able to:

  • Describe the definition, clinical significance, and prevalence of metabolic syndrome (MetS) in adults.
  • Summarize the development and evolution of MetS diagnostic criteria.
  • Assess the impact of metabolic syndrome on cardiovascular, metabolic, and other clinical outcomes.
  • Explain the underlying pathophysiology of MetS, including the role of dysfunctional adipose tissue.
  • Apply evidence-based strategies for the management of metabolic syndrome, including lifestyle interventions and pharmacotherapy.

Topics covered

  • Overview of Metabolic Syndrome (MetS)
  • MetS: Criteria, Clinical Impact, and Pathophysiology
  • Management of MetS

Speaker of this module

Dr_Negi_pic-removebg-preview-modified.png


Dr Anuradha Negi, MBBS MRCP [UK], FAMS [Singapore]

Senior Consultant, Raffles Hospital

Keywords: metabolic syndrome, metabolic syndrome criteria, cardiometabolic risk factors, metabolic syndrome management, cardiometabolic risk management

Something went wrong.